Analytical Data
-
基因名
FCRL3
- Application
-
别名
FCRL3；FCRH3；IFGP3；IRTA3；Fc receptor-like Protein 3
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q96P31
-
表达区间
18-573aa
-
氨基酸序列
GVAPKAVLLLNPPWSTAFKGEKVALICSSISHSLAQGDTYWYHDEKLLKIKHDKIQITEPGNYQCKTRGSSLSDAVHVEFSPDWLILQALHPVFEGDNVILRCQGKDNKNTHQKVYYKDGKQLPNSYNLEKITVNSVSRDNSKYHCTAYRKFYILDIEVTSKPLNIQVQELFLHPVLRASSSTPIEGSPMTLTCETQLSPQRPDVQLQFSLFRDSQTLGLGWSRSPRLQIPAMWTEDSGSYWCEVETVTHSIKKRSLRSQIRVQRVPVSNVNLEIRPTGGQLIEGENMVLICSVAQGSGTVTFSWHKEGRVRSLGRKTQRSLLAELHVLTVKESDAGRYYCAADNVHSPILSTWIRVTVRIPVSHPVLTFRAPRAHTVVGDLLELHCESLRGSPPILYRFYHEDVTLGNSSAPSGGGASFNLSLTAEHSGNYSCDADNGLGAQHSHGVSLRVTVPVSRPVLTLRAPGAQAVVGDLLELHCESLRGSFPILYWFYHEDDTLGNISAHSGGGASFNLSLTTEHSGNYSCEADNGLGAQHSKVVTLNVTGTSRNRTGLT
-
分子量
67.4 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Recombinant Human POLR1C Protein，His
Cat：PA1000-2444
Recombinant Human FERMT2 Protein，His
Cat：PA2000-5150
Protein Description
FCRL3, or Fc receptor-like 3, is a member of the Fc receptor family that plays a significant role in the regulation of immune responses. It is predominantly expressed on B cells and is implicated in various immunological functions, including modulation of antibody responses and T cell interactions. The study of FCRL3 has gained attention due to its potential involvement in autoimmune diseases, cancer, and infectious diseases. Research indicates that FCRL3 may act as an inhibitory receptor, influencing B cell activation and differentiation, which can affect the overall immune landscape. Understanding the structure and function of FCRL3 is crucial for deciphering its roles in these pathological conditions. Recombinant FCRL3 proteins have been developed for functional studies to explore its interactions with ligands and signaling pathways. By investigating the mechanisms of action and regulatory functions of FCRL3, researchers aim to unveil novel therapeutic strategies targeting immune dysregulation, providing insights into designing more effective treatments for related diseases. Additionally, FCRL3's involvement in modulating immune checkpoint pathways is increasingly recognized, marking it as a potential candidate for immunotherapy approaches. Therefore, comprehensive studies of recombinant FCRL3 proteins are vital for advancing our understanding of their biological significance and therapeutic potential in clinical settings.
